Source comparison
CJC-1295 Per Day Daily Dose: DAC vs Non-DAC Protocol Comparison
CJC-1295 with DAC 100–500mcg (typical 200–300mcg) 1–3 times per week 6–8 days Albumin-bound sustained release; amplifies endogenous GH pulses Standard for research requiring stable long-term GH elevation; weekly dosing minimises injection frequency and maintai
This comparison does not assign a generated winner or score.
- CJC-1295 with DAC
- 100–500mcg (typical 200–300mcg)
- 1–3 times per week
- 6–8 days
- Albumin-bound sustained release; amplifies endogenous GH pulses
- Standard for research requiring stable long-term GH elevation; weekly dosing minimises injection frequency and maintains receptor sensitivity
- CJC-1295 without DAC (Mod GRF 1-29)
- 100–200mcg
- 1–3 times per day
- ~30 minutes
- Rapid-acting GHRH analogue; mimics pulsatile secretion
- Requires multiple daily injections; used when researchers want to control exact timing of GH pulses (e.g., pre-sleep dosing)
- Daily Micro-Dosing DAC Version (Error)
- 30–50mcg
- Once daily
- 6–8 days (but never reaches therapeutic level)
- Fragmented receptor engagement; plasma level never stabilises
- Not recommended. Undermines DAC mechanism by preventing sustained elevation; creates erratic GH response
- The comparison clarifies why 'how much CJC-1295 per day' depends entirely on which formulation is being used. DAC-modified CJC-1295 is not dosed daily. Its extended half-life makes weekly or bi-weekly administration the mechanistically correct protocol. Non-DAC CJC-1295 requires daily dosing because it's cleared within 30 minutes, but the dose per injection is lower (100–200mcg) to avoid acute receptor oversaturation. Attempting daily micro-doses of the DAC version creates the worst of both protocols: you lose the sustained amplification benefit while introducing daily injection burden.